Twice-yearly lenacapavir prevents HIV more effectively than daily F/TDF or F/TAF
1. In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir resulted in ...
Tag: public health
MRI-informed biopsy recommendation reduces overdiagnosis in prostate cancer screening
1. In this randomized controlled trial of men aged 50 to 60, forgoing prostate biopsies in those with elevated PSA ...
Communities That HEAL intervention does not reduce opioid-related mortality
1. In this cluster-randomized controlled trial, in communities with a high rate of opioid-related overdoses, the implementation of the Communities ...
Electronic health record-based programs can increase screening for intimate partner violence
1. In a cluster randomized clinical trial, electronic health record (EHR)-based intervention increased the frequency of screening and identifying individuals ...
Newly discovered orthonairovirus is associated with human febrile illnesses
1. A newly found orthonairovirus, Wetland virus (WELV), was discovered to be pathogenic to humans, causing febrile illnesses in northeastern ...
Twice-yearly azithromycin distribution reduces childhood mortality in rural Niger
1. In this randomized cluster trial, twice-yearly azithromycin distribution reduced all-cause childhood mortality among children aged one to 59 months ...
Ultraprocessed food consumption associated with cardiometabolic risk factors in children
1. Preschool-aged children in the top tertile of unprocessed food (UPF) consumption had significantly higher body-mass index (BMI), waist circumference, ...
Wearing surgical masks in public spaces reduces risks of respiratory symptoms
1. Wearing surgical face masks was superior to not wearing surgical face masks in reducing the risk of respiratory symptoms ...
Use of fluoroquinolones and may increase the risk of aortic and mitral regurgitation
1. Patient data from a Taiwanese national database demonstrated that those who took fluoroquinolones had a greater risk of aortic ...
2 Minute Medicine Rewind July 29, 2024
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 1. Six-year follow-up ...
